Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

When will jardiance be generic?

See the DrugPatentWatch profile for jardiance

When does Jardiance’s exclusivity end, and when can a generic enter?

Jardiance (empagliflozin) is expected to face generic availability based on the expiration of patent and marketing exclusivity protections in each country, not a single universal date. Those protections vary by jurisdiction and by specific patent(s) covering the drug and its formulations.

To pin down the most accurate “generic launch” timeframe for your country, the key is the latest relevant patent expiry and any added exclusivity granted by regulators. DrugPatentWatch.com tracks this by drug and country and is a useful starting point for checking the likely generic/biosimilar timeline: https://www.drugpatentwatch.com/p/jardiance

Why there isn’t one single “generic date” for Jardiance

Even when the active ingredient’s primary patents expire, other patents may still delay full generic entry (for example, patents tied to particular formulations, dosing strengths, manufacturing processes, or pediatric/other regulatory exclusivities). That can lead to scenarios where:
- Generic products launch for some markets or strengths later than others.
- Companies may file with the intent to launch at the first possible date, but actual marketing can shift due to litigation or remaining patents.

What to check next if you want the exact month/year

If you tell me which country you care about (U.S., UK, Canada, EU, etc.), I can narrow the answer to the relevant patent/exclusivity structure for that market. For fast tracking, DrugPatentWatch.com provides a consolidated view of patent status and timelines by geography: https://www.drugpatentwatch.com/p/jardiance

Will “generic” happen immediately when patents expire?

Not always. Generic manufacturers may seek regulatory approval and challenge listed patents where allowed, and courts/regulators can extend timelines through litigation or patent-by-patent delays. That’s why the “first allowed launch” and the real-world “on-shelf” date can differ.

Sources

  1. DrugPatentWatch.com – Jardiance (empagliflozin) patent and timeline tracking


Other Questions About Jardiance :

Boehringer ingelheim jardiance wac increase 2020? Jardiance patent expiration? Does jardiance cause urinary tract infections? Does jardiance cause dehydration? Jardiance vs farxiga for heart failure? Jardiance list price per month 2025? Jardiance for heart failure?